Q22. A patient is taking an HMG-CoA reductase inhibitor (statin) and reports muscle aches, soreness, and weakness. The nurse suspects these symptoms to indicate early signs of myopathy. When notifying the physician of these symptoms, the nurse will also be sure to report the results of the patient’s:

Q22. A patient is taking an HMG-CoA reductase inhibitor (statin) and reports muscle aches, soreness, and weakness. The nurse suspects these symptoms to indicate early signs of myopathy. When notifying the physician of these symptoms, the nurse will also be sure to report the results of the patient’s:

Q47. This question is worth 4 points. Identify which antilipidemic medications are used for cholesterol control, which can be used for triglyceride control, or for both cholesterol control and triglyceride control.   

Q37. The “DASH” Diet may be used to help patients with?          

Q32. Your patient who is taking a statin develops abdominal pain in the right upper quadrant and nausea. What lab result below correlates with this finding?  

Q31. The nurse is preparing to administer niacin for the first time to a patient being treated for dyslipidemia. Before administering this medication, the nurse will assess: (Select all that apply.)          

Q10. After teaching the patient about peripheral vascular disease involving disorders of the blood vessels of the arms and legs the nurse asks the patient to name some. Which medical conditions did the patient identify? (Select all that apply.)

Q13. A patient is prescribed a bile acid resin. The nurse instructs the patient to report which adverse reaction related to vitamin K deficiency?

Q18. Which antilipemic agent is the most potent?

Q35. The nurse has just received the lab results for the new patient whose current medications are simvastatin (Zocor) and warfarin (Coumadin). The nurse knows the expected result of the interaction of these drugs is which of the following?